Evidence map›Paper›PMID 32960423›Full record

ArticleActa neurologica Belgica2021

MicroRNA-144 promotes remote limb ischemic preconditioning-mediated neuroprotection against ischemic stroke via PTEN/Akt pathway.

Si-Jin Zhong, Miao-Miao Cui, Yu-Ting Gao, Xue-Yan Cao, Bin Chen, Xian-Ru Wen

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurologica Belgica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Si-Jin Zhong *Department of Clinical, Xuzhou Medical University, Xuzhou, 221004, China.ORCID http://orcid.org/0000-0002-4295-7957
Miao-Miao Cui *Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
Yu-Ting GaoMedical Technology School, Xuzhou Medical University, Xuzhou, 221004, China.
Xue-Yan CaoDepartment of Clinical, Xuzhou Medical University, Xuzhou, 221004, China.
Bin ChenDepartment of Rehabilitation and National Clinical Research Base of Traditional Chinese Medicine, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, 350004, China. chenbin327425224@163.com.ORCID http://orcid.org/0000-0003-3651-8613
Xian-Ru WenDepartment of Genetics, Xuzhou Medical University, Xuzhou, 221004, China. xiangruwen_123@163.com.
Xuzhou Medical College · CNFujian University of Traditional Chinese Medicine · CN

Funding

Jiangsu Students' Platform for innovation and entrepreneurship training program 201810313035Y
6 · The paper itself

Abstract

Ischemic stroke is a refractory disease generally caused by cerebral ischemic injury. Remote ischemic preconditioning (RIPC) caused by transient ischemia and reperfusion of the femoral artery exerts a protective effect on ischemic stroke-induced brain injury. This study was designed to investigate the potential molecular mechanism of RIPC-mediated neuroprotection, namely, the biological effects of microRNA-144 on RIPC in mice with ischemic stroke and its effects on PTEN and Akt signaling pathways. Healthy adult C57BL6 mice were selected for the establishment of middle cerebral artery occlusion (MCAO). One hour before the start, remote ischemic preconditioning of limbs was performed in mice. Brain edema and infarct volume were measured. The expressions of microRNA-144, PTEN, and Akt were measured. The results showed that, compared with MCAO group, the RIPC group protected mice from cerebral ischemia-reperfusion injury, systemic accumulation of inflammatory cytokines, and accelerated apoptosis of parenchymal cells. In RIPC group, PTEN expression decreased, and mir-144 and Akt expression increased. The level of phosphorylated PTEN in the transfected microRNA-144 inhibitor group increased and the level of phosphorylated Akt reduced significantly. In conclusion, our results suggest that microRNA-144 may play a protective role in remote ischemic pretreatment by downregulating PTEN and upregulating Akt, suggesting that microRNA-144 via PTEN/Akt pathway may be of therapeutic significance in ischemic stroke.

Indexed as

AnimalsBrain IschemiaFemaleHindlimbIschemic PreconditioningIschemic StrokeMiceMice, Inbred C57BLMicroRNAsNeuroprotectionPregnancyProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseSignal TransductionMicroRNAsMIRN144 microRNA, mouseProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePten protein, mouseAKTIschemic strokeMicroRNA-144PTENRemote ischemic preconditioning

Identifiers

PMID32960423
OpenAlexW3087432430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.